Drug
Sodium Zirconium Cyclosilicate
Sodium Zirconium Cyclosilicate: highest development phase Post-Market, developed by AstraZeneca, Lupin. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- AstraZeneca, Lupin
Trials
| Drug | Phase | Indication |
|---|---|---|
| Sodium zirconium cyclosilicate NCT06365684 | Post-Market | Hyperkalemia |
| SODIUM ZIRCONIUM CYCLOSILICATE | Approved |
Latest
No recent events.
Follow Sodium Zirconium Cyclosilicate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.